DSNKY Daiichi Sankyo Company Limited Sponsored ADRs

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan. This is an ADR of a company whose stock trades outside of the U.S. as the symbol JT:4568.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$22.75    Pink
As of 01/25/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  Japan
Country of incorporation:  Japan
IPO date:  11/14/2011
Outstanding shares:  1,947,034,029
Average volume:  77,755
Market cap:   $43,671,973,270
Current dividend yield:  1.08%
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.50
PB ratio:   0.03
PS ratio:   0.04
Return on equity:   6.61%
Net income %:   8.57%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy